Athena Trombley
Family · Orange, CANPI 1619402872
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 168 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $857 and has fallen 65.5% since, to $295 in 2025. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 168 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$487
- Lilly USA, LLC$381
- Boehringer Ingelheim$356
- Abiomed$282
- Merck$273
- GSK$222
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,200100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $487 |
| Lilly USA, LLC | 17 | $381 |
| Boehringer Ingelheim | 16 | $356 |
| Abiomed | 13 | $282 |
| Merck | 19 | $273 |
| GSK | 12 | $222 |
| Johnson & Johnson | 7 | $215 |
| AstraZeneca | 11 | $194 |
| AbbVie | 8 | $152 |
| Bayer | 8 | $134 |
| Phathom Pharmaceuticals, Inc. | 6 | $98 |
| Pfizer | 4 | $74 |
| Exact Sciences | 2 | $44 |
| Novartis | 2 | $32 |
| Dexcom, Inc. | 2 | $28 |
| Teleflex LLC | 1 | $28 |
| Exeltis, USA Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Edwards Lifesciences | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Eisai Inc. | 1 | $14 |
How this compares
$3,200 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 38 | $39,588 |
| OzempicSemaglutide | 13 | $21,306 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $2,536 |
| Levothyroxine Sodium | 61 | $1,612 |
| Atorvastatin Calcium | 170 | $1,575 |
| Rosuvastatin Calcium | 42 | $837 |
| Losartan Potassium | 48 | $511 |
| Amlodipine Besylate | 103 | $474 |
| Lisinopril | 58 | $437 |
| Metformin Hcl | 37 | $361 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $359 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 16 | $294 |
| Escitalopram Oxalate | 32 | $224 |
| Doxycycline Hyclate | 27 | $168 |
| Hydrochlorothiazide | 28 | $166 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $356 | $39,58838 claims |
| Novo NordiskOzempic | $487 | $21,30613 claims |
| AstraZenecaSymbicort | $194 | $2,53613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.
Other family in Orange
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.